Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.8K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.8K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.3K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

1.0K
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
1.0K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

1.7K
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.7K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.8K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.8K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.2K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EXPRESS: Spatiotemporal Dynamics of Direct Cortical Response Depression during Spreading Depolarizations.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026
Same author

Pharmacological Profile of Early Sharp Waves in the Neonatal Rat Hippocampus.

Hippocampus·2026
Same author

Dual role of spreading depolarization in an epileptic focus.

Epilepsia·2026
Same author

Action Potential Dynamics During Spreading Depolarization.

Cells·2026
Same author

Auditory evoked delta brushes involve stimulus-specific cortical networks in preterm infants.

iScience·2025
Same author

Comparison of extracellular Giant depolarizing potentials in vitro and early sharp waves in vivo in the CA1 hippocampus of neonatal rats.

Biochemical and biophysical research communications·2024
Same journal

EEG Functional Connectivity Associated With Antidepressant Response to Transcutaneous Electrical Cranial-Auricular Acupoint Stimulation.

CNS neuroscience & therapeutics·2026
Same journal

Cingulate Gradient Dysfunction in End-Stage Renal Disease: Associations With Clinical Phenotypes and Exploratory Transcriptomic Signatures.

CNS neuroscience & therapeutics·2026
Same journal

Dual Antiplatelet Therapy in Acute Branch Atheromatous Disease (BAD)-Related Stroke: A Multicenter Propensity-Matched Cohort Analysis.

CNS neuroscience & therapeutics·2026
Same journal

Postherpetic Neuralgia: Mechanisms, Risk Factors, and Stratified Management-A Narrative Review.

CNS neuroscience & therapeutics·2026
Same journal

FAST BEE (Keeping FAST First): A Public Stroke Education Design to Drive EMS Activation.

CNS neuroscience & therapeutics·2026
Same journal

Conventional MRI-Based Semantic Features for Differentiation of Pediatric Medulloblastoma and Ependymoma in the Fourth Ventricle: Insights From a Multi-Center Retrospective Study.

CNS neuroscience & therapeutics·2026
See all related articles

Related Experiment Video

Updated: Apr 20, 2026

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
07:51

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors

Published on: November 14, 2014

18.1K

Depolarizing GABA and developmental epilepsies.

Roustem Khazipov1, Guzel Valeeva, Ilgam Khalilov

  • 1INMED-INSERM U901, Marseille, France; Aix-Marseille University, Marseille, France; Laboratory of Neurobiology, Kazan Federal University, Kazan, Russia.

CNS Neuroscience & Therapeutics
|December 3, 2014
PubMed
Summary
This summary is machine-generated.

Gamma-aminobutyric acid (GABA) has dual roles in developing brains, exciting immature neurons and influencing network activity. Understanding these effects is key to addressing developmental epilepsies and neonatal seizures.

Keywords:
DevelopmentGABANeonateSeizure

More Related Videos

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.7K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

1.8K

Related Experiment Videos

Last Updated: Apr 20, 2026

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors
07:51

Inhibitory Synapse Formation in a Co-culture Model Incorporating GABAergic Medium Spiny Neurons and HEK293 Cells Stably Expressing GABAA Receptors

Published on: November 14, 2014

18.1K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.7K
Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
08:04

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons

Published on: June 6, 2025

1.8K

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Neurochemistry

Background:

  • Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the adult brain.
  • In immature neurons, GABA exerts depolarizing and dual excitatory/inhibitory effects.
  • These effects are crucial for developing neuronal networks.

Purpose of the Study:

  • To review the properties of excitation and inhibition mediated by depolarizing GABA.
  • To discuss technical challenges in studying GABAergic actions in developing systems.
  • To explore the complex roles of GABA in developmental epilepsies.

Main Methods:

  • Literature review of existing research on GABAergic signaling in development.
  • Analysis of techniques used to study GABAergic synapses.
  • Examination of in vivo and in vitro experimental findings.

Main Results:

  • Depolarizing GABA contributes to enhanced network excitability in immature brains.
  • Repetitive seizures can increase intracellular chloride, potentiating excitatory GABA effects.
  • Altering chloride homeostasis presents a potential therapeutic strategy for neonatal seizures.

Conclusions:

  • Depolarizing GABA plays a significant role in developmental neurological disorders, particularly epilepsy.
  • Understanding GABA's dual actions is critical for therapeutic interventions.
  • Strategies targeting chloride homeostasis may offer new treatments for neonatal seizures.